Financhill
Back

Applied Therapeutics 10K Form

Sell
27

APLT
Applied Therapeutics

Last Price:
$0.88
Seasonality Move:
5.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive APLT News And Ratings

See the #1 stock for the next 7 days that we like better than APLT

APLT Financial Statistics

Sales & Book Value

Annual Sales: $10M
Cash Flow: $-23.3M
Price / Cash Flow: 0
Annual Sales: $0.05
Price / Book: 17.38

Profitability

EPS (TTM): -1.61000
Net Income (TTM): $-187.3M
Gross Margin: --
Return on Equity: -797.82%
Return on Assets: -192.86%

Applied Therapeutics Earnings Forecast

Key Applied Therapeutics Financial Ratios

  • The Research & Development expenses have been 539.43% of Revenue.
  • The Net Earning history of APLT is -1,198.47% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Applied Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APLT
CUSIP: 03828A
Website: appliedtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.06
Quick Ratio: 1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLT Technical Analysis vs Fundamental Analysis

Sell
27
Applied Therapeutics (APLT) is a Sell

Is Applied Therapeutics a Buy or a Sell?